focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Nice one and with further publicity in the coming week we may see some interest from serious big investors.
Hopefully we will get some positive figures and a confident outlook for the summer.
Don’t usually take much notice of broker share price forecasts but £2.50 doesn’t seem unreasonable.
Allesandro what valuation yard stick are you using to calculate a fair share price?
A tad disappointing and £200m in the bank doing nothing?
Some figures due tomorrow. May stir some interest.
Thanks for this. I’m in Directa still, having sold VRS when they called in the turn around guys.
Surely it’s time for these type of companies to merge to save on research development and admin costs.
And construction companies need to embrace the technology in cement road surfaces and volume business.
If I recall the VRS flooring put in at their factory site was going to be an example of how it was the material of the future with only modest amounts of graphene added.
Materially enhance earnings was the phrase used when we got the Royal Navy contract. Let’s hope there are more orders in the pipeline after today from other countries to get this relatively modest capitalised company in the news.
So a company listed on Tokyo exchange has brought the intellectual and other stuff off SED.
Anyone know if we can buy into that share to try and cut our losses?
If on the 18th March they expected an agreement by end of the first quarter that is some 2weeks away! What went wrong or what on earth did they think they were doing making an announcement which was in effect not true or they could not guarantee.
Well having put the cap round they had to say something!
Long term investors have heard this time and time again have we fallen for it again?
Another treatment approved by FDA. Well done all the research teams. GSK building another range of products with significant potential.
If we can get an agreement with the US courts on Zantac we could see a significant re rating for GSK especially with $ earnings.
This share is looking very sick what is going to put us out of our misery?
Will shareholders get any info on the winding up?
Not expecting any return but still perplexed why despite an environmentally useful product and apparently sane management no one has bought the company. Surely some Indian billionaire would be interested in transforming the tuk tuk in their country.
So assume the business plan was wrong or is it just we aren’t American!
A real shame this co failed not just the investor losses but the inability for engineering skills to develop.
Wow stab jackets AND environmentally friendly cartons soon we will be millionaires.
The RNS refers to testing when the sweet oil goes to Quadrise for conversion to MSAR . Is that a formality as the appears to be ready to market/ sell on straight away?
I’m no scientist just want LTHs to hear we are selling something to someone!
Sorry for your loss. The expectations for graphene and its spin offs seem to be less realistic than first thought.Perhaps not in terms of scientific advancement but translating the process in to a profitable entity. Is it just a case of waiting to get the stuff accepted by the construction industry , pot hole fillers and other sectors where the volume potential exist or is the wonder material dressing a king with no clothes on!
Even DirectaPlus with EU help is struggling to convince shareholders and potential investors it’s the miracle the world needs.
At least the continued share buy back will be more cost effective at these levels! I assume that’s the case accountancy wise?